CPDC Funds Research at CAMH for Developing Alk2-Targeting Pet Tracer for Diagnosis of Pediatric Brain Cancer

HAMILTON, ON and TORONTO, ON, July 6, 2023 – The Centre for Probe Development and Commercialization (CPDC) is pleased to announce a collaboration with Dr. Neil Vasdev at the Centre for Addiction and Mental Health (CAMH) to develop a novel positron emission tomography (PET) tracer specific for the activin receptor-like kinase 2 (ALK2) protein. Under … Read more

CPDC Funds Research at Simon Fraser University for Developing an LAT1-Targeting PET Tracer for Imaging Cancer

HAMILTON, ON and VANCOUVER, BC, July 4, 2023 – The Centre for Probe Development and Commercialization (CPDC) is proud to announce its funding of a new research project led by Dr. Robert Britton at Simon Fraser University (SFU) aimed at developing a novel positron emission tomography (PET) tracer that targets the L-type amino acid transporter … Read more